Guardian Pharmacy Stock Target Price and Analyst Consensus
| GRDN Stock | 24.94 0.02 0.08% |
Analysts of Guardian Pharmacy render investment recommendations by dissecting financials, analyzing earning calls, and talking to Guardian Pharmacy vendors, executives, and customers to validate their buy-or-sell advice. Unfortunately, the analyst consensus on Guardian Pharmacy is currently unavailable. Please use our comprehensive buy-or-sell advice module to check the latest Macroaxis investment opinion on Guardian Pharmacy
As of the 2nd of December 2024, Gross Profit is likely to drop to about 193.2 M. At this time, Guardian Pharmacy's Non Current Assets Total are very stable compared to the past year. As of the 2nd of December 2024, Non Currrent Assets Other is likely to grow to about 365.4 K, while Other Current Liabilities is likely to drop about 8.8 M. Guardian |
It's important to approach Guardian Pharmacy's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Guardian Pharmacy price targets
Guardian Pharmacy's stock target price is an estimate of its future price, usually made by analysts. Using Guardian Pharmacy's target price to determine if it is a suitable investment can be done through the following steps:- Look at Guardian Pharmacy's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Guardian Pharmacy's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Guardian Pharmacy Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Guardian Pharmacy is a key component of Guardian Pharmacy valuation and have some predictive power on the future returns of a Guardian Pharmacy.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardian Pharmacy's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested few shares | |
 | Online Gaming Invested few shares | |
 | Disruptive Technologies Invested one share | |
 | SRI Sustainable Growth Invested few shares | |
 | Size And Style ETFs Invested few shares | |
 | Alternative Energy Invested over 20 shares | |
 | Corona Opportunity Invested one share | |
 | Trump Equities Invested one share | |
 | Millennials Best Invested few shares | |
 | Automobiles and Trucks Invested over 200 shares |
Check out Macroaxis Advice on Guardian Pharmacy to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.